David Goesling

David Goesling is Inventprise Chief Financial Officer, he is a tenured financial executive with extensive startup and growth phase experience in both private and publicly traded corporations. Dave has been a key senior management leader in multiple leading-edge technology and life science companies and has completed a broad spectrum of equity, bank, and debt financings, raising billions of dollars in the aggregate to fuel growth. He has implemented complex financial systems and created process and infrastructure to enable scalable growth and cost efficiency. Dave has held senior financial management positions at development and commercial stage pharmaceutical and medical device companies for the past 15 years, including the development from pre-FDA approval to sale of RF Surgical Systems to Medtronic and a reverse merger transaction creating Armata Pharmaceuticals (ARMP) which is now in clinical trials evaluating engineered phage-based treatments.